Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Following publication of the original article [1], the authors identified a number of errors. In Result (P.3), Table 1 (P.4), Table 5 (P.9) and Supplementary Table 1, the correct unit for adiponectin was μg/mL. I...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Tags: Correction Source Type: research

Related Links:

ConclusionsSerum lipid profile is not associated with IPFD in healthy non-obese. Triglycerides, but not other components of lipid profile, is a promising biomarker for IPFD in individuals following acute pancreatitis.
Source: Nutrition, Metabolism and Cardiovascular Diseases - Category: Nutrition Source Type: research
Conclusions. The prevalence of metabolic syndrome observed among the study population was 90.6%, with a higher percentage in females than males. High triglyceride levels and high waist circumference were the main risk factors for MS in the diabetic population. PMID: 31187045 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
So much time and energy have been wasted these past 40 or so years in trying to reduce dietary fat, including saturated fat. All you need do is look around you to see the result: the most unhealthy, fattest, most diabetic population in history, prescribed more drugs, more reliant on this (corrupt and unhelpful) thing called modern healthcare, with people in healthcare such as your doctor blaming YOU, rather than themselves and their misguided message. After all, doctors and dietitians are following the dictates of the U.S. Dietary Guidelines for Americans and the USDA food plate that carries the blessings of Big Food and a...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Low-fat diet grain-free low-carb undoctored wheat belly Source Type: blogs
AbstractThe aim of this study was to assess the effects of different dietary approaches on low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglyceride (TG) levels in patients with type 2 diabetes (T2D) by applying network meta-analysis (NMA). Systematic electronic and hand searches were conducted until January 2018. Randomized controlled trials (RCTs) with an intervention period of  ≥ 12 weeks, focussing on adults with T2D, and comparing dietary approaches regarding LDL, HDL or TGs, were included. For each outcome measure, random effects NMA was performed in...
Source: European Journal of Epidemiology - Category: Epidemiology Source Type: research
Fractyl Laboratories made a pretty bold statement with its interim data from the INSPIRE trial at the American Diabetes Association's 79th Scientific Sessions in San Francisco this past weekend. The investigator-initiated INSPIRE clinical study showed that Fractyl’s Revita Duodenal Mucosal Resurfacing (DMR) System can help eliminate the need for daily insulin injections for type 2 diabetes patients. “[Revita DMR] … is now showing real promising efficacy in patients who are taking daily injections for their type 2 diabetes already,” Harith Rajagopalan...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news
Large international study explores role of dulaglutide Related items fromOnMedica Statin use link to heightened type 2 diabetes risk in some people Diabetes prescriptions rise by a third in last five years US expert group updates statins recommendations Drug could cut heart events by 26% in diabetics Metformin doesn ’t help HbA1c in teens with type 1 diabetes
Source: OnMedica Latest News - Category: UK Health Source Type: news
Drug delays diabetes onset a median of 2 years Related items fromOnMedica Statin use link to heightened type 2 diabetes risk in some people Type 2 diabetes drugs vary in impact on survival NICE approves extra ‘triple therapy’ drug for diabetes Study claims medical treatment can reverse type 2 diabetes Drug could cut heart events by 26% in diabetics
Source: OnMedica Latest News - Category: UK Health Source Type: news
Conclusiondyslipidemia is highly prevalent among diabetic population particularly in those with poorly controlled diabetes. This calls for early and universal screening of lipid profile. There is also an urgent demand for measures that target tight glycemic, optimal lipid profile control and life style modifications is also required to all diabetic patients to achieve target value of HbA1C ≤ 7.
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Authors: Choromanska B, Mysliwiec P, Hady HR, Dadan J, Mysliwiec H, Bonda T, Chabowski A, Miklosz A Abstract Obesity is characterised by imbalance in lipid metabolism manifested by high concentrations of circulating triacylglycerols and total cholesterol as well as low high-density lipoprotein (HDL) levels. Abnormalities related to these lipids lead to metabolic complications such as type 2 diabetes, arterial hypertension and cardiovascular disease. Despite extensive research, it is still unclear why a subset of obese subjects develop metabolic syndrome, while others do not. The aim of our work was to assess total ...
Source: Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research
CONCLUSION: In postmenopausal women with T2DM, elevated levels of specific plasma ceramides are associated with higher plasma hs-CRP levels independent of established cardiovascular risk factors, diabetes-related variables and other potential confounding factors. PMID: 31185304 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Tags: Diabetes Metab Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Heart | Januvia